Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?

Marcin Chwistek, Dylan Sherry, Leigh Kinczewski, Maria J. Silveira, Mellar Davis

Research output: Contribution to journalComment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science